0001127602-15-012337.txt : 20150323 0001127602-15-012337.hdr.sgml : 20150323 20150323174532 ACCESSION NUMBER: 0001127602-15-012337 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150319 FILED AS OF DATE: 20150323 DATE AS OF CHANGE: 20150323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLACKSON TIMOTHY P CENTRAL INDEX KEY: 0001242992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 15719993 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-03-19 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242992 CLACKSON TIMOTHY P C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 President, R&D, CSO Common Stock 2015-03-19 4 M 0 10833 0 A 439065 D Common Stock 2015-03-19 4 M 0 20657 7.56 A 460971 D Common Stock 2015-03-19 4 S 0 20657 9.00 D 440314 D Common Stock 2015-03-20 4 S 0 5417 8.8443 D 433648 D Common Stock 2015-03-23 4 M 0 13333 0 A 446981 D Common Stock 2015-03-23 4 S 0 6667 8.552 D 440314 D Restricted Stock Units 2015-03-19 4 M 0 10833 0 D Common Stock 10833 10833 D Employee Stock Option (Right to Buy) 7.56 2015-03-19 4 M 0 20657 0 D 2006-10-04 2015-10-04 Common Stock 20657 0 D Restricted Stock Units 2015-03-23 4 M 0 13333 0 D Common Stock 13333 0 D Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013. Shares were acquired upon the exercise of outstanding stock options at $7.56 per share. Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan. Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012. Shares were acquired upon the exercise of outstanding stock options at $9.00 per share. Each restricted stock unit represents a right to receive one share of ARIAD common stock. Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016 Restricted Stock Units vest as to 33-1/3% of the award on March 20, 2013, March 20, 2014 and March 20, 2015. /s/Edward M. Fitzgerald, Attorney-in-Fact 2015-03-23